31 related articles for article (PubMed ID: 12171901)
21. Clinical role of polyamine analysis: problem and promise.
Jeevanandam M; Petersen SR
Curr Opin Clin Nutr Metab Care; 2001 Sep; 4(5):385-90. PubMed ID: 11568499
[TBL] [Abstract][Full Text] [Related]
22. Growth status significantly affects the response of human lung cancer cells to antitumor polyamine-analogue exposure.
Carlisle DL; Devereux WL; Hacker A; Woster PM; Casero RA
Clin Cancer Res; 2002 Aug; 8(8):2684-9. PubMed ID: 12171901
[TBL] [Abstract][Full Text] [Related]
23. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives.
Seiler N
Curr Drug Targets; 2003 Oct; 4(7):565-85. PubMed ID: 14535655
[TBL] [Abstract][Full Text] [Related]
24. Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues.
Casero RA; Frydman B; Stewart TM; Woster PM
Proc West Pharmacol Soc; 2005; 48():24-30. PubMed ID: 16416654
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of polyamine metabolism: review article.
Wallace HM; Fraser AV
Amino Acids; 2004 Jul; 26(4):353-65. PubMed ID: 15290341
[TBL] [Abstract][Full Text] [Related]
26. Selective regulation of polyamine metabolism with methylated polyamine analogues.
Keinänen TA; Hyvönen MT; Alhonen L; Vepsäläinen J; Khomutov AR
Amino Acids; 2014 Mar; 46(3):605-20. PubMed ID: 24022706
[TBL] [Abstract][Full Text] [Related]
27. Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment.
Davidson NE; Hahm HA; McCloskey DE; Woster PM; Casero RA
Endocr Relat Cancer; 1999 Mar; 6(1):69-73. PubMed ID: 10732790
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
